Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects. (2018)

First Author: Jones NG
Attributed to:  Proteolysis and life cycle progression in Leishmania funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.7b00244

PubMed Identifier: 29384366

Publication URI: http://europepmc.org/abstract/MED/29384366

Type: Journal Article/Review

Volume: 4

Parent Publication: ACS infectious diseases

Issue: 4

ISSN: 2373-8227